Citigroup Maintains Neutral on Ziff Davis, Lowers Price Target to $62
$ZD
Telecommunications Equipment
Telecommunications
Citigroup analyst Ygal Arounian maintains Ziff Davis (NASDAQ:ZD) with a Neutral and lowers the price target from $74 to $62.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/2/2024 | $70.00 | Neutral → Overweight | JP Morgan |
| 9/25/2023 | $81.00 | Neutral | UBS |
| 1/6/2023 | $88.00 | Equal Weight | Barclays |
| 12/13/2022 | $100.00 | Neutral | Citigroup |
| 9/20/2022 | $90.00 | Outperform | Evercore ISI |
| 12/15/2021 | $150.00 | Buy | Citigroup |
| 11/30/2021 | $150.00 | Outperform | Wedbush |
| 11/15/2021 | $163.00 → $155.00 | Market Outperform | JMP Securities |
10-Q - ZIFF DAVIS, INC. (0001084048) (Filer)
8-K - ZIFF DAVIS, INC. (0001084048) (Filer)
S-8 - ZIFF DAVIS, INC. (0001084048) (Filer)
4 - ZIFF DAVIS, INC. (0001084048) (Issuer)
4 - ZIFF DAVIS, INC. (0001084048) (Issuer)
4 - ZIFF DAVIS, INC. (0001084048) (Issuer)
In the latest quarter, 5 analysts provided ratings for Ziff Davis (NASDAQ:ZD), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 2 2 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $62.4, with a high estimate of $70.00 and a low estimate of $52.00. Observing a downward trend, the current average is 11.49% lower
Citigroup analyst Ygal Arounian maintains Ziff Davis (NASDAQ:ZD) with a Neutral and lowers the price target from $62 to $52.
Shares of SeaStar Medical Holding Corporation (NASDAQ:ICU) fell sharply during Wednesday's session after the company entered into a $10 million registered direct offering of 947,868 shares at $10.55 per share. SeaStar Medical shares dipped 34% to $8.55 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares jumped 139% to $2.78 after the company announced results for a Swine Model pilot study for Probudur. Kazia Therapeutics Limited (NASDAQ:KZIA) gained 129% to $0.4325 after the company announced results from GBM-AGILE, a phase II/III study that included an evaluation of paxalisib versus standard of
JP Morgan upgraded Ziff Davis from Neutral to Overweight and set a new price target of $70.00
UBS initiated coverage of Ziff Davis with a rating of Neutral and set a new price target of $81.00
Barclays initiated coverage of Ziff Davis with a rating of Equal Weight and set a new price target of $88.00
SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)
SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)
SC 13G - ZIFF DAVIS, INC. (0001084048) (Subject)
Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the third quarter ended September 30, 2024. "We are very pleased with our third quarter results," said Vivek Shah, Chief Executive Officer of Ziff Davis. "We are seeing improvements in the businesses that we currently own, as well as opportunities to leverage our strong balance sheet and free cash flows to acquire businesses that we would like to own." THIRD QUARTER 2024 RESULTS Q3 2024 quarterly revenues increased 3.7% to $353.6 million compared to $341.0 million for Q3 2023. Loss from operations increased to $29.3 million compared to $13.3 million for Q3 2023. This includes a
Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the second quarter ended June 30, 2024. "Our recent acquisition activity gives us confidence that we are back on the path to steady and compounding growth," said Vivek Shah, Chief Executive Officer of Ziff Davis. "We are prepared to continue to act with conviction and decisiveness on accretive, value-driving opportunities." SECOND QUARTER 2024 RESULTS Q2 2024 quarterly revenues decreased 1.6% to $320.8 million compared to $326.0 million for Q2 2023. Income from operations decreased 26.5% to $28.6 million compared to $38.9 million for Q2 2023. Net income (1) increased to $
Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the first quarter ended March 31, 2024. "Our first quarter financial results are some of the Company's strongest since the second quarter of 2022," said Vivek Shah, Chief Executive Officer of Ziff Davis. "We are particularly pleased with the growth in our subscription and licensing revenues, as we continue to pursue a balanced business model." FIRST QUARTER 2024 RESULTS Q1 2024 quarterly revenues increased 2.4% to $314.5 million compared to $307.1 million for Q1 2023. Income from operations increased 36.3% to $35.9 million compared to $26.3 million for Q1 2023. Net inco
Ziff Davis, Inc. (NASDAQ:ZD), today announced its participation in one investor conference in December. Details of the conference are as follows: UBS Global Technology and AI Conference Location: The Phoenician, Scottsdale, AZ Date and time: December 4, 2024, 9:35 am (MT) Webcast: https://cc.webcasts.com/ubsx001/120224a_js/?entity=95_HCFT6OJ About Ziff Davis Ziff Davis (NASDAQ:ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, connectivity, health and wellness, cybersecurity, and martech. For more information, visit www.ziffdavis.com. View source version on businesswire.com:
Powered by Aberdeen Strategy & Research, the Annual Report Will Be Showcased at SpiceWorld, Where Industry Expert Peter Tsai Will Share Key Findings Spiceworks, a leader in IT insights and solutions, launches its 13th Annual State of IT report, providing a comprehensive outlook on rising costs, workforce demands, and the impacts of generative AI. Released in partnership with Aberdeen Strategy & Research, the report sheds light on essential strategies for IT resilience and growth in 2025. The 2025 report highlights the growing importance of security, the rising cost of IT resources, and the critical need for talent development in the face of skills shortages, providing companies with a r
Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the third quarter ended September 30, 2024. "We are very pleased with our third quarter results," said Vivek Shah, Chief Executive Officer of Ziff Davis. "We are seeing improvements in the businesses that we currently own, as well as opportunities to leverage our strong balance sheet and free cash flows to acquire businesses that we would like to own." THIRD QUARTER 2024 RESULTS Q3 2024 quarterly revenues increased 3.7% to $353.6 million compared to $341.0 million for Q3 2023. Loss from operations increased to $29.3 million compared to $13.3 million for Q3 2023. This includes a
4 - ZIFF DAVIS, INC. (0001084048) (Issuer)
Ziff Davis, Inc. (NASDAQ:ZD) will release its Third Quarter 2024 Earnings at 6:00PM ET on Thursday, November 7, 2024. Additionally, Ziff Davis invites the public, members of the press, the financial community, stockholders, and other interested parties to listen to a live audio Webcast of its Third Quarter 2024 Earnings Call at 8:30AM ET on Friday, November 8, 2024. Vivek Shah, Chief Executive Officer, and Bret Richter, Chief Financial Officer, will host the call. Materials presented during the call will be posted on the Company's web site at ziffdavis.com and furnished as an exhibit to the Company's 8-K filed with the Securities and Exchange Commission pursuant to Regulation FD in connect
2024 list recognizes 336 leading Hispanic and Latino doctors in the nationNEW YORK, NY / ACCESSWIRE / September 17, 2024 / Castle Connolly today announced the release of the Castle Connolly 2024 Top Hispanic & Latino Doctors, recognizing 336 outstanding physicians from Hispanic and Latino communities. This year's list reflects a 44% increase in recognized doctors compared to the 2023 list and represents 73 specialties across 35 states. Castle Connolly 2024 Top Hispanic & Latino Doctors This distinction is part of Castle Connolly's Diversity Equity and Inclusion (DEI) initiative, designed to honor top clinicians and enable patients to find Castle Connolly Top Doctors who have shared backgro
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from